RMC No. 106-2018 publicizes the immediate duty of government offices, GOCCs, and SUCs to support the anti-illegal drugs campaign.
Government offices, government-owned or controlled corporations, and state universities and colleges were directed to immediately mobilize their assets and take an active role in the government’s anti-illegal drugs campaign. For businesses, contractors, suppliers, and regulated entities dealing with the BIR or other government agencies, RMC No. 106-2018 matters because it signals a government-wide compliance environment where anti-illegal drug policies may affect internal government operations, public sector contracting, workplace coordination, and agency-level implementation of national policy.
What RMC No. 106-2018 Changed
RMC No. 106-2018 was issued by the Bureau of Internal Revenue on December 7, 2018 to publish the full text of Memorandum Circular No. 53 dated November 12, 2018. The memorandum circular directed all government offices, agencies, and instrumentalities, including government-owned or controlled corporations and state universities and colleges, to take an active role in the anti-illegal drugs campaign.
The most important compliance point is not a new tax rate, withholding rule, VAT rule, or filing threshold. Instead, the key directive is institutional mobilization. Government entities were instructed to immediately mobilize their assets and participate in the government’s anti-illegal drugs campaign, in accordance with their respective mandates.
For the BIR, the circular was addressed to all internal revenue officials, employees, and others concerned. All concerned were enjoined to be guided accordingly and to give the circular as wide publicity as possible. This means the issuance is primarily an internal government guidance and publication measure, but it also has practical relevance for taxpayers and businesses that routinely interact with revenue officials and other public offices.
Who Is Affected by RMC No. 106-2018
The directly affected parties are government offices, agencies, instrumentalities, government-owned or controlled corporations, and state universities and colleges. Within the BIR, the audience includes internal revenue officials, employees, and others concerned.
Private taxpayers are not directly given a new tax filing obligation under RMC No. 106-2018. The issuance does not impose a new income tax rate, VAT rate, excise tax rate, withholding tax remittance schedule, documentary stamp tax requirement, or registration deadline. It also does not identify a new BIR form or prescribe a tax return attachment.
However, businesses may still be affected in practice. Government contractors, service providers, lessors, concessionaires, suppliers, professional service firms, and companies dealing with GOCCs, SUCs, and government agencies may encounter agency-level policies or coordination measures connected to the anti-illegal drugs campaign. Employers with public sector contracts should also be alert to compliance language in bids, accreditation documents, workplace policies, and representations required by government counterparties.
Legal and Policy Background
Memorandum Circular No. 53 cites Republic Act No. 9165, otherwise known as The Comprehensive Dangerous Drugs Act of 2002. Under that law, the Dangerous Drugs Board is identified as the policy-making and strategy-formulating body for drug prevention and control, while the Philippine Drug Enforcement Agency is identified as the agency responsible for efficient and effective law enforcement of relevant provisions on dangerous drugs, controlled precursors, and essential chemicals.
The memorandum circular also refers to Executive Order No. 15, series of 2017, which created the Inter-Agency Committee on Anti-Illegal Drugs and the National Anti-Illegal Drug Task Force. It further cites Executive Order No. 66, series of 2018, which institutionalized the Philippine Anti-Illegal Drugs Strategy and directed government offices, including GOCCs and SUCs, to implement that strategy in accordance with their respective mandates.
The policy basis stated in the issuance is that the drug problem continues to degrade the moral fiber of society, undermine the rule of law, and evolve as a national security problem. This explains why the directive is framed as a whole-of-government instruction rather than a narrow revenue regulation.
Key Compliance Requirement and Deadline
The operative instruction in Memorandum Circular No. 53 is immediate. All government offices, agencies, and instrumentalities, including GOCCs and SUCs, were directed to immediately mobilize their assets and take an active role in the government’s anti-illegal drugs campaign, in accordance with their respective mandates.
The issuance date of RMC No. 106-2018 is December 7, 2018. The underlying Memorandum Circular No. 53 is dated November 12, 2018. For search and compliance tracking purposes, accountants and corporate officers may encounter this matter using phrases such as RMC 106-2018 anti-illegal drugs campaign, Memorandum Circular No. 53 government offices, BIR anti-illegal drugs campaign issuance, GOCC anti-drug compliance, and government agency anti-illegal drugs directive.
Because the directive is mandate-based, each government office is expected to act within its own legal authority. For businesses, the practical point is to check whether the government office they deal with has adopted specific requirements, contract clauses, workplace access rules, reporting protocols, accreditation conditions, or supplier compliance representations connected to this policy.
Penalties for Non-Compliance
RMC No. 106-2018 does not state a specific tax penalty, surcharge, interest, compromise penalty, administrative fine, or criminal penalty for private taxpayers. It also does not prescribe a separate penalty table for government offices that fail to comply with the directive.
This is important for CFOs, accountants, and tax practitioners. The issuance should not be treated as creating a new BIR assessment exposure by itself. There is no stated deficiency tax consequence, no new tax return, and no separate payment deadline in the text of RMC No. 106-2018.
Nevertheless, companies should avoid dismissing the issuance as irrelevant. In regulated industries and government-facing transactions, compliance obligations may arise indirectly through agency rules, bid documents, contracts, memoranda, accreditation requirements, internal workplace policies, or coordination requests issued by the relevant government body implementing its mandate.
Practical Steps for Businesses and Tax Teams
First, determine whether your company deals with any covered public entity, such as a government agency, GOCC, SUC, or government instrumentality. If yes, review existing contracts, procurement documents, and accreditation requirements for any anti-illegal drugs campaign, workplace safety, employee screening, compliance certification, or public policy cooperation clauses.
Second, government contractors should ensure that their internal policies are consistent with lawful workplace rules. Any drug-free workplace policy, testing program, disciplinary process, or employee undertaking must still comply with applicable labor, privacy, occupational safety, and due process requirements. The fact that the government promotes an anti-illegal drugs campaign does not remove the need for legally sound implementation by private employers.
Third, tax and compliance officers should classify RMC No. 106-2018 correctly in their internal issuance trackers. It should be tagged as a BIR publication of a presidential memorandum circular concerning government participation in the anti-illegal drugs campaign, not as a revenue regulation imposing a tax payment obligation.
Fourth, companies responding to government bids or public sector engagements should confirm whether the procuring entity has issued supplemental bid bulletins, documentary requirements, or compliance undertakings connected to anti-illegal drug policies. Where declarations are required, businesses should ensure that signatories have proper authority and that statements are accurate.
How Ablola, Saribong & Gueco Can Help
RMC No. 106-2018 is a reminder that not every BIR issuance creates a new tax payment, but many BIR issuances still matter for regulatory compliance, public sector dealings, and business risk management. Companies need to know whether an issuance affects tax filings, contracts, procurement, employee policies, or government-facing obligations.
Ablola, Saribong & Gueco assists corporations, SMEs, government contractors, accounting teams, and in-house counsel in interpreting BIR issuances, preparing compliance trackers, reviewing government contract requirements, and aligning internal policies with Philippine tax, labor, corporate, and regulatory law. For assistance with BIR compliance and government-facing business requirements, contact Ablola, Saribong & Gueco through MakatiLawFirm.com.